Trial Profile

Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease (PAD) Patients With Type 2 Diabetes (T2D)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 22 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aspirin (Primary) ; Ticagrelor (Primary)
Indications Peripheral arterial occlusive disorders; Type 2 diabetes mellitus
Focus Therapeutic Use

Most Recent Events

18 Mar 2019 Results assessing the effectiveness of ticagrelor and aspirin than aspirin monotherapy in patients with lower extremity arterial disease and type 2 diabetes mellitus, presented at the 68th Annual Scientific Session of the American College of Cardiology.
01 Nov 2018 Status changed from recruiting to completed.
26 Sep 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com